Skip to main content

Detection of West Nile virus genome and specific antibodies in Iranian encephalitis patients

  • S. CHINIKAR (a1), A. JAVADI (a2), B. ATAEI (a2), H. SHAKERI (a2), M. MORADI (a1), E. MOSTAFAVI (a1) and S. M. GHIASI (a1)...

West Nile virus (WNV) is a mosquito-borne flavivirus which circulates in birds, horses and humans. An estimated 80% of WNV infections are asymptomatic. Fewer than 1% of infected persons develop neuroinvasive disease, which typically presents as encephalitis, meningitis, or acute flaccid paralysis. This study was conducted from January 2008 to June 2009 in Isfahan, Iran. Patients attending the emergency department with fever and loss of consciousness were consecutively included. Cerebrospinal fluids (CSF) were initially analysed through bacteriology and biochemistry examinations, resulting in those with evidence of meningitis being excluded. Patients' CSF and serum were diagnosed by serological and molecular assays. A total of 632 patients with fever and loss of consciousness were tested by CSF analyses. Samples of the remaining patients (39·4%) were referred for WNV investigation. Three (1·2%) of the patients were positive for both serum and CSF by RT–PCR, and six (2·4%) were positive only for IgG antibodies. History of insect bite, and blood transfusion and transplantation were risk factors for being positive by RT–PCR (P=0·048) and being IgG positive (P=0·024), respectively. The results of this study showed that the prevalence of West Nile fever is low in patients with encephalitis.

Corresponding author
*Author for correspondence: Dr B. Ataei, Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran. (Email:
Hide All
1. Hayes E, Gubler D. West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States. Annual Review of Medicine 2006; 57: 181194.
2. Beasley DWC, Barrett ADT. Virulence of West Nile virus in different animal hosts. In Diamond MS, ed. West Nile Encephalitis Virus Infection . New York: Springer, 2009, pp. 137153.
3. Petersen L, Marfin A, Gubler D. West Nile virus. Journal of the American Medical Association 2003; 290: 524.
4. Fonseca K, et al. West Nile virus infection and conjunctival exposure. Emerging Infectious Diseases 2005: 11: 16481649.
5. Gyure K. West Nile virus infections. Journal of Neuropathology & Experimental Neurology 2009; 68: 1053.
6. Nash D, et al. The outbreak of West Nile virus infection in the New York City area in 1999. New England Journal of Medicine 2001; 344: 1807.
7. Giladi M, et al. West Nile encephalitis in Israel, 1999: the New York connection. Emerging Infectious Diseases 2001; 7: 659.
8. Lanciotti R, et al. Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science 1999; 286: 2333.
9. Saidi S. Viral antibodies in preschool children from the Caspian area, Iran. Iranian Journal of Public Health 1974; 3: 8391.
10. Saidi S, et al. The prevalence of human infection with West Nile in Iran. Iranian Journal of Public Health 1974; 5: 8–14.
11. Huhn G, Dworkin M. Rash as a prognostic factor in West Nile virus disease. Clinical Infectious Diseases 2006; 43: 388389.
12. Asnis D, et al. The West Nile virus outbreak of 1999 in New York: the Flushing hospital experience. Clinical Infectious Diseases 2000; 30: 413418.
13. Chowers M, et al. Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerging Infectious Diseases 2001; 7: 675.
14. Ergünay K, et al. West Nile virus seroprevalence in blood donors from central Anatolia, Turkey. Vector-Borne and Zoonotic Diseases 2009; 10: 199202.
15. Zeller H, Schuffenecker I. West Nile virus: an overview of its spread in Europe and the Mediterranean basin in contrast to its spread in the Americas. European Journal of Clinical Microbiology & Infectious Diseases 2004; 23: 147156.
16. Hamdan A, et al. Possible benefit of intravenous immunoglobulin therapy in a lung transplant recipient with West Nile virus encephalitis. Transplant Infectious Disease 2002; 4: 160162.
17. Mostashari F, et al. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet 2001; 358: 261264.
18. O'Leary D, et al. The epidemic of West Nile virus in the United States, 2002. Vector-Borne and Zoonotic Diseases 2004; 4: 6170.
19. Corrigan R, et al. Prediction of human cases of West Nile virus by equine cases, Saskatchewan, Canada, 2003. Preventive Veterinary Medicine 2006; 76: 263272.
20. Tilley P, et al. Screening of organ and tissue donors for West Nile virus by nucleic acid amplification – a three year experience in Alberta. American Journal of Transplantation 2008; 8: 21192125.
21. Petersen L, Roehrig J. West Nile virus: a reemerging global pathogen. Emerging Infectious Diseases 2001; 7: 611614.
22. Klee A, et al. Long-term prognosis for clinical West Nile virus infection. Emerging Infectious Diseases 2004; 10: 14051411.
23. Tsai T, et al. West Nile encephalitis epidemic in southeastern Romania. Lancet 1998; 352: 767771.
24. Hubalek Z, Halouzka J. West Nile fever – a reemerging mosquito-borne viral disease in Europe. Emerging Infectious Diseases 1999; 5: 643.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Full text views

Total number of HTML views: 1
Total number of PDF views: 14 *
Loading metrics...

Abstract views

Total abstract views: 142 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 20th November 2017. This data will be updated every 24 hours.